首页> 外文学位 >Humoral immunity in mice after allogeneic bone marrow transplantation.
【24h】

Humoral immunity in mice after allogeneic bone marrow transplantation.

机译:同种异体骨髓移植后小鼠的体液免疫。

获取原文
获取原文并翻译 | 示例

摘要

A number of genetic diseases have been treated with hematopoietic stem cell transplantation (HSCT) for decades. In particular, severe combined immune deficiency (SCID) is a primary immune deficiency that results from a number of inherited mutations. Few patients are fortunate enough to have a human leukocyte antigen (HLA)-identical donor, thus many are transplanted with a semi-matched graft. Although stem cell transplantation can be a life saving treatment, in many, reconstruction of the immune system is delayed resulting in high incidences of infectious disease. The delay in immune reconstitution is most apparent in the B cell compartment. Many patients have not exhibited an ability to produce protective antibodies thus requiring long-term immunoglobulin replacement therapy. Improved understanding of the nature of these defects may lead to more efficacious therapies.; In addition to genetic diseases certain malignancies are also being treated with HSCT. Although most patients receive an autologous or HLA-identical graft, a significant population receives a semi-matched transplant. In these patients, delayed B cell reconstitution and function results in substantial non-relapse associated morbidity and mortality. Improvement of B cell immunity may result from enhancing our knowledge of the inferred deficiencies in B cell function.; The goal of this thesis project was to further our understanding of humoral immunity following transplantation with allogeneic bone marrow. Surprisingly, little has been done in mouse models to address the presumed defects in B cell differentiation. The work presented here is among the first to assess the state of humoral competence after BM transplantation. The studies in this thesis revealed a lesion in higher order B cell immunity after in utero transplantation of allogeneic or haploidentical bone marrow in SLID mice. In the case of allogeneic transplant recipients, our results suggested this lesion resulted from inefficient selection of T helper cells, which drive B cell differentiation. We have also shown irradiated adult mice reconstituted with haploidentical BM exhibited normal B cell function. These results are in contrast to human recipients of semi-matched grafts and more work is required to adequately model the human status of humoral function following transplantation.
机译:数十年来,造血干细胞移植(HSCT)已治疗了许多遗传疾病。特别地,严重的联合免疫缺陷(SCID)是由许多遗传突变导致的主要免疫缺陷。很少有患者幸运地拥有与人类白细胞抗原(HLA)相同的供体,因此许多患者都进行了半匹配的移植。尽管干细胞移植可以挽救生命,但在许多情况下,免疫系统的重建却被延迟,导致高传染性疾病的发生。免疫重建的延迟在B细胞区室中最为明显。许多患者没有表现出产生保护性抗体的能力,因此需要长期的免疫球蛋白替代疗法。对这些缺陷的性质的进一步了解可能会导致更有效的治疗。除遗传疾病外,HSCT还可以治疗某些恶性肿瘤。尽管大多数患者都接受自体或HLA相同的移植物,但仍有相当一部分人群接受了半匹配的移植物。在这些患者中,延迟的B细胞重建和功能导致大量非复发相关的发病率和死亡率。 B细胞免疫力的提高可能是由于我们对推断的B细胞功能缺陷的认识增强所致。本项目的目的是加深我们对异体骨髓移植后体液免疫的了解。出人意料的是,在小鼠模型中几乎没有进行任何工作来解决B细胞分化中的假定缺陷。这里介绍的工作是最早评估BM移植后体液能力状态的研究之一。本论文的研究揭示了在同种异体或单倍体骨髓子宫内移植SLID小鼠后,病灶的B细胞免疫水平更高。对于同种异体移植受者,我们的结果表明该病变是由于T辅助细胞选择效率低下导致的,该T辅助细胞驱动B细胞分化。我们还显示了用单倍体BM重建的辐照成年小鼠表现出正常的B细胞功能。这些结果与半匹配移植物的人类接受者相反,需要更多的工作来充分模拟移植后人体的体液功能状况。

著录项

  • 作者

    Carlson, Michael Joseph.;

  • 作者单位

    The University of Iowa.;

  • 授予单位 The University of Iowa.;
  • 学科 Health Sciences Immunology.
  • 学位 Ph.D.
  • 年度 2006
  • 页码 162 p.
  • 总页数 162
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 预防医学、卫生学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号